Click on the Lecture title to view video
#
Day 3 Proceedings Author
     
Session 1- Madangopalan Oration: Management of symptomatic portal cavernomacholangiopathy (PCC): Lessons and Insights  
1
Madangopalan Oration: Management of symptomatic portal cavernomacholangiopathy (PCC): Lessons and Insights V.A Saraswat
Session 2- State of the Art Lecture - 1: Immunology of liver: Clinical implication  
1
State of the Art Lecture - 1: Immunology of liver: Clinical implication S.M.F Akbar
Session 3- Symposium on DILI  
1
Recognizing, assessing andmanaging DILI in liver disease Patrick Kamath
2
ATT induced hepatotoxicity- risk factor and management L Venkatakrishnan
3
CAM and DILI in India H Devarbhavi
Session 4- Symposium on Vascular Disorders of the Liver  
1
Prevention of PCC and its complications S.A Zargar
2
Budd-Chiari Syndrome- when to consider LT? Sunil Taneja
3
Role of anticoagulation in EHPVO and BCS in India Akash Shukla
4
Veno-occlusive disease (SOS) and small hepatic vein obstruction CE Eapen
5
PVT in cirrhosis -lone bystander or an insult. Does it need treatment? Sharat Putta
Session 5- Symposium on Critical Care in Liver Cirrhosis  
1
Hemodynamics monitoring and fluid balance Ashish Kumar
2
Risk factors, outcome and prevention of bacterial infections in end-stage liver disease Dinesh Jotimani
3
Is there a role for palliative care in cirrhosis patients admitted to the ICU Puneeta Tandon

   © 2017 INASL. All rights reserved.